Haya Therapeutics in a $65M series A with Sofinnova Partners, Schroders Capital, +ND Capital,
02 May 2025
02 May 2025
Total investments received (USD): 65M
Round value (USD): 65M
Company: Haya Therapeutics
Related deals
Nuclidium in a €84M series B with Kurma Fund, Angelini Ventures, Wellington Partners, Neva SGR, DTCF, Bayern Kapital, Eurazeo, NRW and HighLight Capital
Investments
01 July 2025
Mosanna Therapeutics raised an $80M Series A round co-led by Pivotal bioVenture Partners and EQT, with Forbion, Broadview Ventures, and Norwest Ventures.
Investments
01 June 2025
ReproNovo raises $65 million in a series A round co-led by AXA IM Alts and M Ventures, joined by Ysios Capital, Jeito and ALSA Ventures
Investments
10 May 2025
Granite Bio raised $70m in Series B funding led by Forbion and Sanofi Ventures
Investments
06 April 2025
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal